Concepedia

Markus Wahrmann

MW

52

Publications

2.8K

Citations

31

H-Index

1999

Active since

Affiliations

Medical University of Vienna(Current)

University of Alberta

The Metabolomics Innovation Centre

University of Vienna

Statistics Austria

Markus Wahrmann is an author at Medical University of Vienna specializing in medicine, immunology, and kidney transplant.

ORCID

Top concepts

Publications per year

1999–2023

52

Publications

52

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

Farsad Eskandary, Heinz Regele, Lukas Baumann et al. · Journal of the American Society of Nephrology · 2017 · 288 citations · Full text

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

Heinz Regele, Markus Exner, Bruno Watschinger et al. · Nephrology Dialysis Transplantation · 2001 · 234 citations

A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

Konstantin Doberer, Michael Duerr, Philip F. Halloran et al. · Journal of the American Society of Nephrology · 2020 · 162 citations · Full text

Immunoadsorption in Severe C4d-Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial

GA Böhmig, Markus Wahrmann, Heinz Regele et al. · American Journal of Transplantation · 2006 · 140 citations · Full text

CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection

Konstantin Doberer, Johannes Kläger, Guido A. Gualdoni et al. · Transplantation · 2020 · 110 citations

Rows per page

1–5 of 52